HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neuronal expression of TATA box-binding protein containing expanded polyglutamine in knock-in mice reduces chaperone protein response by impairing the function of nuclear factor-Y transcription factor.

Abstract
The polyglutamine diseases consist of nine neurodegenerative disorders including spinocerebellar ataxia type 17 that is caused by a polyglutamine tract expansion in the TATA box-binding protein. In all polyglutamine diseases, polyglutamine-expanded proteins are ubiquitously expressed throughout the body but cause selective neurodegeneration. Understanding the specific effects of polyglutamine-expanded proteins, when expressed at the endogenous levels, in neurons is important for unravelling the pathogenesis of polyglutamine diseases. However, addressing this important issue using mouse models that either overly or ubiquitously express mutant polyglutamine proteins in the brain and body has proved difficult. To investigate the pathogenesis of spinocerebellar ataxia 17, we generated a conditional knock-in mouse model that expresses one copy of the mutant TATA box-binding protein gene, which encodes a 105-glutamine repeat, selectively in neuronal cells at the endogenous level. Neuronal expression of mutant TATA box-binding protein causes age-dependent neurological symptoms in mice and the degeneration of cerebellar Purkinje cells. Mutant TATA box-binding protein binds more tightly to the transcription factor nuclear factor-Y, inhibits its association with the chaperone protein promoter, as well as the promoter activity and reduces the expression of the chaperones Hsp70, Hsp25 and HspA5, and their response to stress. These findings demonstrate how mutant TATA box-binding protein at the endogenous level affects neuronal function, with important implications for the pathogenesis and treatment of polyglutamine diseases.
AuthorsShanshan Huang, Joseph J Ling, Su Yang, Xiao-Jiang Li, Shihua Li
JournalBrain : a journal of neurology (Brain) Vol. 134 Issue Pt 7 Pg. 1943-58 (Jul 2011) ISSN: 1460-2156 [Electronic] England
PMID21705419 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • CCAAT-Binding Factor
  • Endoplasmic Reticulum Chaperone BiP
  • HSPA5 protein, human
  • Hspa5 protein, mouse
  • Intermediate Filament Proteins
  • Molecular Chaperones
  • NES protein, human
  • Nerve Tissue Proteins
  • Nes protein, mouse
  • Nestin
  • Peptides
  • TATA-Box Binding Protein
  • TBP protein, human
  • nuclear factor Y
  • polyglutamine
Topics
  • Age Factors
  • Animals
  • Body Weight (genetics)
  • Brain (metabolism, pathology)
  • CCAAT-Binding Factor (genetics, metabolism)
  • Cell Line, Transformed
  • Chromatin Immunoprecipitation (methods)
  • Disease Models, Animal
  • Endoplasmic Reticulum Chaperone BiP
  • Female
  • Gene Expression Regulation (genetics)
  • Humans
  • Intermediate Filament Proteins (deficiency)
  • Male
  • Mice
  • Mice, Transgenic
  • Molecular Chaperones (genetics, metabolism)
  • Nerve Tissue Proteins (deficiency)
  • Nestin
  • Neurodegenerative Diseases (genetics, pathology)
  • Neurons (metabolism, pathology)
  • Peptides (genetics, metabolism)
  • TATA-Box Binding Protein (genetics, metabolism)
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: